Wellness tech company Korea Lighting is formally launching a device that harnesses the power of infrared (IR) light to boost cognitive function. The “Neurélux” lamp will be making its debut at this year’s Consumer Electronics Show in Las Vegas, running from Jan. 6-9.
In a press release on New Year’s Day, the company announced the upcoming milestone. It will mark Korea Lighting’s entry into the American home healthcare and sleep tech markets, as specified by founder and CEO Dongwoo Lee.
He has described the gadget as being an innovative bridge between lighting and cognitive wellness support. The product has been designed as a daily desk lamp that converts into a brain wellness device. It is slated to become available to international customers in March.
“Unlike wearable devices or clinical equipment, Neurélux delivers non-contact, dual-IR light designed to gently enhance cerebral blood flow and support cognitive wellness,” he explained in a LinkedIn posting last month, “using the science of light, not pharmaceuticals.”
Korea Lighting says it has received New Excellent Technology and News Excellent Product certifications from South Korea’s government for Neurélux and other devices. The company has crafted Neurélux to boost cognitive function and enhance sleep, but the technology it uses has much broader range of treatment indications.
Read more: Sleep tech mattress cover startup ‘Orion’ takes on Eight Sleep
Tech is being used for TBI & neurodegenerative diseases
Photobiomodulation or transcranial photobiomodulation is an emerging therapy that uses infrared wavelengths that pass through the top of the skull and make contact with the brain to improve cognitive health.
This variety of treatment has been gaining steam because of its promising potential for preventing and treating neurodegenerative illnesses like Alzheimer’s, Parkinson’s and dementia. Additionally, photobiomodulation technology has garnered interest for helping patients who have suffered traumatic brain injuries.
“This fresh perspective on photobiomodulation places Korea Lighting at the forefront of functional light design for brain health and daily wellbeing,” Dongwoo Lee stated on social media.
As highlighted by Korea Lighting in a recent video shared to social media, several peer-reviewed studies and reviews have reported positive outcomes for transcranial photobiomodulation. Since 2020, there has been a rapid increase in the number of clinical trials studying the technology for brain health indications, building on previous positive findings.
They have shown that specific near-infrared wavelengths (810 nanometres and 1,064 nanometres) can enhance cerebral blood flow. Neurélux uses both of these wavelengths simultaneously.
Transcranial photobiomodulation is not FDA approved, yet, and its use remains primarily within research and wellness contexts rather than standard medical treatment. While peer-reviewed studies and systematic reviews indicate promising benefits in areas like cerebral blood flow and cognitive performance, the evidence remains preliminary. Many trials are small-scale or pilot studies and larger randomized controlled trials are needed to confirm long-term efficacy and consistency across populations.
Read more: Ozlo’s collaboration with Calm combines sleep aid tech with meditation soundscapes
Follow Rowan Dunne on LinkedIn
rowan@mugglehead.com
